{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:28:30Z","timestamp":1780723710207,"version":"3.54.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,10]]},"DOI":"10.7759\/cureus.94269","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:32:04Z","timestamp":1760095924000},"source":"Crossref","is-referenced-by-count":1,"title":["Cutaneous Pseudolymphomas of the Scalp Secondary to Lamotrigine"],"prefix":"10.7759","author":[{"given":"Juliana M","family":"O'Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2\u00a0weeks of drug exposure: A retrospective study","volume":"82","author":"Soria A","year":"2020","unstructured":"Soria A, Bernier C, Veyrac G, Barbaud A, Puymirat E, Milpied B. Drug reaction with eosinophilia and systemic symptoms may occur within 2\u00a0weeks of drug exposure: A retrospective study. J Am Acad Dermatol. 2020, 82:606-11. 10.1016\/j.jaad.2019.09.036","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2019.07.003","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting","volume":"72","author":"Fowler T","year":"2019","unstructured":"Fowler T, Bansal AS, Lozs\u00e1di D. Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting. Seizure. 2019, 72:61-70. 10.1016\/j.seizure.2019.07.003","journal-title":"Seizure"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3182491c31","article-title":"Lamotrigine-induced lupus-like syndrome: a case report and literature review","volume":"21","author":"Chang RS","year":"2014","unstructured":"Chang RS, Cole AJ. Lamotrigine-induced lupus-like syndrome: a case report and literature review. Am J Ther. 2014, 21:e85-7. 10.1097\/MJT.0b013e3182491c31","journal-title":"Am J Ther"},{"key":"ref4","article-title":"Dermatology, 4th ed","author":"Bolognia JL","year":"2012","unstructured":"Bolognia JL, Jorizzo JL, Schaffer J V. Dermatology, 4th ed. Elsevier Saunders, Philadelphia, PA; 2012."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13951","article-title":"Drug-induced cutaneous pseudolymphoma: a systematic review of the literature","volume":"64","author":"Etesami I","year":"2023","unstructured":"Etesami I, Kalantari Y, Tavakolpour S, Mahmoudi H, Daneshpazhooh M. Drug-induced cutaneous pseudolymphoma: a systematic review of the literature. Australas J Dermatol. 2023, 64:41-9. 10.1111\/ajd.13951","journal-title":"Australas J Dermatol"},{"key":"ref6","article-title":"Lamotrigine-induced cutaneous pseudolymphoma","volume":"104","author":"Reed KL","year":"2019","unstructured":"Reed KL, Quinn KB, Gust AJ. Lamotrigine-induced cutaneous pseudolymphoma. Cutis. 2019, 104:E1-3.","journal-title":"Cutis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.07.040","article-title":"Multifocal and recurrent cutaneous pseudolymphoma associated with lamotrigine and review of the literature","volume":"28","author":"Kazemi S","year":"2022","unstructured":"Kazemi S, Simmons E, Kiuru M, Tartar DM. Multifocal and recurrent cutaneous pseudolymphoma associated with lamotrigine and review of the literature. JAAD Case Rep. 2022, 28:44-8. 10.1016\/j.jdcr.2022.07.040","journal-title":"JAAD Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602972","article-title":"FDA regulation of prescription drugs","volume":"376","author":"Gassman AL","year":"2017","unstructured":"Gassman AL, Nguyen CP, Joffe HV. FDA regulation of prescription drugs. N Engl J Med. 2017, 376:674-82. 10.1056\/NEJMra1602972","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408111-cutaneous-pseudolymphomas-of-the-scalp-secondary-to-lamotrigine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:32:05Z","timestamp":1760095925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408111-cutaneous-pseudolymphomas-of-the-scalp-secondary-to-lamotrigine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.94269","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,10]]}}}